









市場
/
株式
/
nasdaq-qtrx
/

Quanterix Corp

QTRX

6.090USD

+0.210+3.57%

終値 02/06, 16:00（ET）15分遅れの株価

284.30M時価総額

損失額直近12ヶ月PER



Quanterix Corp

6.090

+0.210+3.57%

概要金融分析企業名

概要

金融

分析

企業名

詳細情報 Quanterix Corp 企業名

Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.

Quanterix Corpの企業情報



企業コードQTRX

会社名Quanterix Corp

上場日Dec 07, 2017

最高経営責任者「CEO」Toloue (Masoud)

従業員数471

証券種類Ordinary Share

決算期末Dec 07

本社所在地900 Middlesex Turnpike

都市BILLERICA

証券取引所NASDAQ OMX - NASDAQ BASIC

国United States of America

郵便番号01821

電話番号16173019400

ウェブサイトhttps://www.quanterix.com/

企業コードQTRX

上場日Dec 07, 2017

最高経営責任者「CEO」Toloue (Masoud)

Quanterix Corpの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

282.30K

-1817.00%

Mr. William P. (Bill) Donnelly

Executive Chairman of the Board

140.51K

+2377.00%

Ms. Karen A. Flynn

Independent Director

49.78K

+23372.00%

Mr. Scott Mendel

Director

31.59K

+25316.00%

Dr. Myla P. Lai-Goldman, M.D.

Director

30.34K

+25316.00%

Mr. Jeffrey Thomas (Jeff) Elliott

Lead Independent Director

27.33K

+23372.00%

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

9.95K

-4395.00%

Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.

Independent Director

Dr. Garret Hampton, Ph.D.

Independent Director

Dr. Alan Sachs, M.D., Ph.D.

Independent Director

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

282.30K

-1817.00%

Mr. William P. (Bill) Donnelly

Executive Chairman of the Board

140.51K

+2377.00%

Ms. Karen A. Flynn

Independent Director

49.78K

+23372.00%

Mr. Scott Mendel

Director

31.59K

+25316.00%

Dr. Myla P. Lai-Goldman, M.D.

Director

30.34K

+25316.00%

Mr. Jeffrey Thomas (Jeff) Elliott

Lead Independent Director

27.33K

+23372.00%

収益内訳

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q2

FY2024Q1

FY2023

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

事業別USD

会社名

収益

比率

Product revenue

26.15M

0.00%

Service and other revenue

13.95M

0.00%

Collaboration and license revenue

46.00K

0.00%

地域別USD

会社名

収益

比率

North America

24.39M

0.00%

EMEA

11.08M

0.00%

Asia Pacific

4.68M

0.00%

事業別

地域別

事業別USD

会社名

収益

比率

Product revenue

26.15M

0.00%

Service and other revenue

13.95M

0.00%

Collaboration and license revenue

46.00K

0.00%

株主

更新時刻: Fri, Nov 21

株主統計

種類

株主統計

比率

Portolan Capital Management, L.L.C.

9.12%

Columbia Threadneedle Investments (UK)

6.71%

BlackRock Institutional Trust Company, N.A.

6.12%

The Vanguard Group, Inc.

5.73%

Telegraph Hill Partners

5.36%

他の

66.95%

株主統計

比率

Portolan Capital Management, L.L.C.

9.12%

Columbia Threadneedle Investments (UK)

6.71%

BlackRock Institutional Trust Company, N.A.

6.12%

The Vanguard Group, Inc.

5.73%

Telegraph Hill Partners

5.36%

他の

66.95%

種類

株主統計

比率

Investment Advisor/Hedge Fund

37.10%

Investment Advisor

22.29%

Hedge Fund

12.26%

Individual Investor

6.30%

Private Equity

5.36%

Research Firm

4.36%

Pension Fund

0.44%

Bank and Trust

0.20%

Family Office

0.13%

他の

11.56%

機関投資家保有株



更新時刻: Thu, Jan 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q4

383

38.26M

81.91%

-7.44M

2025Q3

384

34.11M

73.41%

-9.53M

2025Q2

391

36.46M

81.18%

-12.95M

2025Q1

401

40.45M

104.19%

-6.42M

2024Q4

388

38.02M

98.63%

-6.28M

2024Q3

386

36.47M

95.03%

-5.94M

2024Q2

394

35.66M

93.20%

-9.57M

2024Q1

395

35.56M

93.43%

-9.17M

2023Q4

388

34.77M

91.99%

-10.35M

2023Q3

382

36.53M

97.35%

-9.84M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

Portolan Capital Management, L.L.C.

4.26M

9.12%

+626.23K

+17.23%

Sep 30, 2025

Columbia Threadneedle Investments (UK)

3.14M

6.71%

+8.77K

+0.28%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

2.86M

6.12%

+212.22K

+8.01%

Sep 30, 2025

The Vanguard Group, Inc.

2.65M

5.67%

+118.56K

+4.69%

Sep 30, 2025

Telegraph Hill Partners

2.50M

5.36%

+2.50M

Sep 30, 2025

Walt (David R)

1.86M

3.99%

+2.59K

+0.14%

Oct 01, 2025

Invenomic Capital Management LP

1.39M

2.98%

+248.10K

+21.67%

Sep 30, 2025

William Blair Investment Management, LLC

1.32M

2.82%

+187.30K

+16.60%

Sep 30, 2025

Easterly Investment Partners LLC

1.25M

2.68%

+168.55K

+15.55%

Sep 30, 2025

Millennium Management LLC

1.21M

2.59%

+1.20M

+9880.18%

Sep 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

配当落ち日

種類

比率

データなし

日付

配当落ち日

種類

比率

データなし

KeyAI



Quanterix Corp

詳細情報 Quanterix Corp 企業名

Quanterix Corpの企業情報

Quanterix Corpの経営陣

収益内訳

株主

機関投資家保有株

株主動向

関連ETF

配当金

株式分割